Adare Pharma Relocating Headquarters from New Jersey to Northeast Philadelphia

By

Adare Pharma Solutions exterior at Dungan Road in Philadelphia.
Image via Adare Pharma Solutions.
Adare Pharma Solutions is moving its headquarters from New Jersey to Northeast Philadelphia, as part of a $16.8 million expansion project.

Adare Pharma Solutions is relocating its headquarters to Northeast Philadelphia from New Jersey as part of a $16.8 million expansion project, writes John George for the Philadelphia Business Journal.

The company will also open a new lab at the new location and expects to create 115 new jobs within the next three years.

Adare, which received $3 million in state support for the move, said it will keep 200 existing jobs in Pennsylvania.

The company was awarded a $2.4 million loan from the Pennsylvania Industrial Development Authority, as well as a $460,000 Pennsylvania First grant provided by the state’s Department of Community and Economic Development. It also received a $100,000 workforce development grant from the state.

Adare plans to expand two of its existing Philadelphia manufacturing and packaging facilities and add new a headquarters at a Dungan Road location.

Adare Pharma CEO Tom Sellig said that in addition to the state support, the company decided to move to Philadelphia due to the region’s continued growth as a life sciences hub.

“It is crucial for us to have access to a highly skilled talent pool and key markets, and the Philadelphia area provides exactly what we need,” he said.

Read more about Adare Pharma ahead of its move in the Philadelphia Business Journal.

_____

Connect With Your Community

Subscribe for stories that matter!

"*" indicates required fields

This field is hidden when viewing the form
PT Yes
Advertisement